Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2016 Sep 21;5(2):410–419.e4. doi: 10.1016/j.jaip.2016.08.001

FIGURE 3.

FIGURE 3

PBMC mRNA gene expression (A) at baseline and (B) after triamcinolone. (C) Pathway analysis of significant genes (P <.05) in children who did not achieve control with triamcinolone (note: TNF, P > .05). Red and green arrows depict upregulation and downregulation, respectively. Gray lines depict reported or probable associations. Gray circles represent genes that were not tested.